What to know (if you’re still paying attention):
- Aubrai, a decentralized AI agent, has an audacious plan to revolutionize longevity research using blockchain and DAOs. Because nothing says “trust us” like a robot funding lab rats with cryptocurrency. 🧬
- The AUBRAI token lets holders play God with research funding. Finally, your chance to decide if we should cure aging or just fund a better meme coin. 🚀
- Combines AI with “human expertise,” which is either genius or a cry for help. Jury’s out. 🤖
Longevity research has collided with crypto like a trainwreck in a sci-fi novel. Enter Aubrai, a decentralized science (DeSci) project launched on Base, because obviously. The Bio Protocol’s latest brainchild aims to fix the “valley of death” where good ideas go to starve while venture capitalists sip margaritas in Bali.
DeSci, for the uninitiated, uses blockchain to fund experiments, reward contributors with tokens, and turn labs into crypto casinos. No longer must scientists rely on dreary things like “grants” or “ethics.” Now they can just mint IP-tokens and pray to Satoshi. 🙏
The AUBRAI token-because every revolution needs a currency-grants holders governance rights over funding. Imagine a world where your vote on telomere research hinges on how many tokens you’ve mined. Truly, democracy reimagined. 🗳️
Built by VitaDAO, Bio Protocol, and Aubrey de Grey’s LEV Foundation (yes, *that* Aubrey), Aubrai promises to bridge the “valley of death.” You know, where capital markets flee and labs subsist on stale croissants and philanthropist pity. 🍞
De Grey, the man who thinks aging is a “curable condition” (bless his heart), claims traditional funding is a “chronic gap.” No kidding. Turns out venture capitalists aren’t keen on investing in something that might outlive them. 🤔
Aubrai’s masterstroke? Feeding de Grey’s unpublished lab data into an AI. Because nothing could possibly go wrong with a robot writing science experiments based on a single man’s notes. 🤡
Once experiments are “validated” (read: vaguely plausible), discoveries become IP-tokens. Pharma companies can license them, and profits flow back to… everyone except the lab tech who actually did the work. Capitalism, baby! 💰
The RMR2 mouse study-because obviously it’s mice again-is already a circus. Aubrai “suggested” tweaks that humans later noticed. Groundbreaking. Next, it’ll invent the wheel. 🐭
“Transformative for our planning pipeline,” de Grey gushed. One imagines him weeping with joy as the AI flagged dosing errors. Meanwhile, the mice are just trying to avoid being the 100th victim of “science.” 🧪
Paul Kohlhaas, Bio Protocol’s founder, insists this is the “creator economy” for scientists. Because nothing says “creative” like a tokenized lab rat. 🎨
DeSci’s challenges (i.e., Why This Might Explode)
Tokenized IP will *definitely* attract regulators. Pharma firms will balk at buying cures dreamed up by an AI and a DAO. But hey, if it works, blockchain could do more than pump memecoins. It could fund actual science! Imagine that. 🤯
Will Aubrai succeed? Maybe. Will it crash and burn like Theranos in a crypto hoodie? Also maybe. Either way, someone’s getting rich, and someone else is getting a book deal. 📚
Read More
- Gold Rate Forecast
- Pepe Price: Can the Meme King Rise Again? 🤑🚀
- LINK PREDICTION. LINK cryptocurrency
- EUR USD PREDICTION
- Silver Rate Forecast
- ETH PREDICTION. ETH cryptocurrency
- Brent Oil Forecast
- GBP EUR PREDICTION
- ADA PREDICTION. ADA cryptocurrency
- INJ PREDICTION. INJ cryptocurrency
2025-08-25 16:38